Advertisement
Advertisement
U.S. Markets open in 1 hr 51 mins
Advertisement
Advertisement
Advertisement
Advertisement

Precigen, Inc. (PGEN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.0000-0.0400 (-1.32%)
At close: 04:00PM EST
3.0100 +0.01 (+0.33%)
After hours: 04:36PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.0400
Open3.0900
Bid2.9700 x 1800
Ask3.3200 x 2200
Day's Range2.9900 - 3.1729
52 Week Range2.9900 - 9.8900
Volume1,641,469
Avg. Volume1,450,688
Market Cap620.214M
Beta (5Y Monthly)2.29
PE Ratio (TTM)N/A
EPS (TTM)-0.5650
Earnings DateFeb 28, 2022 - Mar 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.20
  • PR Newswire

    Precigen Provides Pipeline and Corporate Updates at the 40th Annual J.P. Morgan Healthcare Conference

    Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today presented pipeline and corporate updates at the 40th Annual J.P. Morgan Healthcare Conference. Helen Sabzevari, PhD, President and CEO of Precigen, presented a summary of 2021 achievements and set forth Precigen's goals for 2022.

  • Zacks

    Here's Why Precigen, Inc. (PGEN) Could be Great Choice for a Bottom Fisher

    Precigen, Inc. (PGEN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

  • PR Newswire

    Precigen to Present at the 40th Annual J.P. Morgan Healthcare Conference

    Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, PhD, President and CEO of Precigen, will present a corporate and clinical overview at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 3:45 PM ET.

Advertisement
Advertisement